DRKS00004739招募中未知
ProImmun Study- Influence of an endurance exercise program on the immune function and quality of life of prostate cancer patients undergoing Antiandrogen- or Chemotherapy - ProImmun Study
Stiftung Leben mit Krebs0 个研究点目标入组 80 人开始时间: 2013年3月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Male
入选标准
- •Patients with advanced prostate cancer receiving Antiandrogen therapy for at least 4 weeks or
- •Patients with advanced prostate cancer receiving Antiandrogen therapy in combination with chemotherapy (baseline test before chemotherapy)
- •Hemoglobin > 9g/dl
- •Ejection fraction > 60%
- •forced expiratory volume in one second > 50%
- •Age > 18 years
- •Expectation of life > 6 month
- •Written consent
- •Inconspicuous ultrasound of the patients heart
- •Inconspicuous ECG (rest and stress)
排除标准
- •Anemia < 8g/dl
- •Platelet count < 10000/µl
- •CNS Metastasis
- •Planned Surgery
- •Heart failure (NYHA III-IV)
- •Coronary disease
- •Therapy refractory Hypertension
- •Other internistic diseases that unable patients to exercise
- •Orthopedic handicaps that unable patients to exercise
- •Psychological problems which are critical in view of the responsible medical doctor
研究者
相似试验
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 13.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023444-32-DKGlaxoSmithKline341
进行中（未招募）
不适用
A study to evaluate lung treatment and exercise tolerance of COPD patients with a new bronchodilator: GSK573719/GW642444Moderate/severe chronic obstructive pulmonary disease (COPD).MedDRA version: 13.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023442-75-EEGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444 - N/AModerate/severe chronic obstructive pulmonary disease (COPD).MedDRA version: 14.0Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023442-75-DEGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444. - n/aChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 13.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-023444-32-GBGlaxoSmithKline341
进行中（未招募）
不适用
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444.Chronic Obstructive Pulmonary Disease (COPD)MedDRA version: 12.1Level: LLTClassification code 10010952Term: COPDEUCTR2010-023444-32-CZGlaxoSmithKline341